Petros Pharmaceuticals Inc (PTPI PINK) stock market data APIs
$0.009
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
Petros Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Prev. Close
0.009
Open
0.012
High
0.012
Low
0.0079
52 wk Range
0.008-16.25
Market Cap
381 K
Shares Outstanding
42 372 K
Revenue
5 112 K
EPS
-0.03
Beta
1.716
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Petros Pharmaceuticals Inc data using free add-ons & libraries
Get Petros Pharmaceuticals Inc Fundamental Data
Petros Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 5 112 K
- EBITDA: -7 716 996
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Petros Pharmaceuticals Inc News
New
Delisting of Securities from The Nasdaq Stock Market
Nasdaq, Inc. NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.’s common stock was sus...
CBIZ (CBZ) Stock Trades Down, Here Is Why
What Happened? Shares of financial services provider CBIZ (NYSE:CBZ) fell 3.1% in the morning session after analysts at William Blair lowered their earnings estimates for the company. This revision b...
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical co...
The Urvan Group Issues Letter to AMMO Inc. Shareholders Regarding its Nomination of a Full Slate of Highly Qualified Candidates for Election to the Company’s Board of Directors
Delivers Overview of New Strategy for Leveraging AMMO’s Existing Assets and Evolving the Company into a Diversified, Growing and Profitable Ecommerce Powerhouse Highlights Long-Term Opportunity to ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
